FDA Approves Daclatasvir + Sofosbuvir for Hard-to-Treat Hepatitis C Patients

Press/Media: Press / Media

PeriodFeb 12 2016

Media coverage

1

Media coverage

  • TitleFDA Approves Daclatasvir + Sofosbuvir for Hard-to-Treat Hepatitis C Patients
    Media name/outletHIV and Hepatitis.com
    CountryUnited States
    Date2/12/16
    PersonsFred Poordad